Acadia Pharmaceuticals | ACAD - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
ALKERMES USD 338.34M 72.51M 2025-12
Alnylam Pharmaceuticals USD 829.31M 219.56M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Cytokinetics USD 17.76M 15.82M 2025-12
Eisai JPY 168.85B 17.02B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Incyte USD 1.17B 217.51M 2026-03
J&J USD 17.24B 642M 2026-03
Moderna USD 226M 583M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Prothena USD 21K 2.39M 2025-12
PTC Therapeutics USD 148.38M 39.31M 2025-12
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12